Noninvasive glucose sensing.

The ability to measure glucose noninvasively in human subjects is a major objective for many research groups. Success will revolutionize the treatment of diabetes by providing a means to improve glycemic control, thereby delaying the onset of the medical complications associated with this disease. This article focuses on the current state of the art and attempts to identify the principal areas of research necessary to advance the field. Two fundamentally different approaches are identified for the development of noninvasive glucose sensing technology. The indirect approach attempts to measure glucose on the basis of its effect on a secondary process. The direct approach is based on the unique chemical structure of the glucose molecule. Advances for each approach are limited by issues of selectivity. Several critical parameters are discussed for the direct approach, including issues related to the optical path length, wavelength range, dimensionality of the multivariate calibration model, net analyte signal, spectral variance, and assessment of the chemical basis of measurement selectivity. A set of publication standards is recommended as a means to enhance progress toward a successful noninvasive monitor.

[1]  K. Tachibana,et al.  Transdermal delivery of insulin by ultrasonic vibration , 1991, The Journal of pharmacy and pharmacology.

[2]  R. Guy,et al.  Sonophoresis. II. Examination of the Mechanism(s) of Ultrasound-Enhanced Transdermal Drug Delivery , 1992, Pharmaceutical Research.

[3]  S. Mitragotri,et al.  Combined Effect of Low-Frequency Ultrasound and Iontophoresis: Applications for Transdermal Heparin Delivery , 2000, Pharmaceutical Research.

[4]  J. Kost,et al.  Ultrasonically controlled polymeric drug delivery , 1988 .

[5]  J. Simonin On the mechanisms of in vitro and in vivo phonophoresis , 1995 .

[6]  R. Guy,et al.  Sonophoresis. I. The Use of High-Frequency Ultrasound to Enhance Transdermal Drug Delivery , 1992, Pharmaceutical Research.

[7]  J. McElnay,et al.  Use of ultrasound to enhance percutaneous absorption of benzydamine. , 1989, Physical therapy.

[8]  S. Mitragotri,et al.  Theoretical description of transdermal transport of hydrophilic permeants: application to low-frequency sonophoresis. , 2001, Journal of pharmaceutical sciences.

[9]  J Kost,et al.  Effect of ultrasound on transdermal drug delivery to rats and guinea pigs. , 1989, The Journal of clinical investigation.

[10]  S. Mitragotri,et al.  A mechanistic study of ultrasonically-enhanced transdermal drug delivery. , 1995, Journal of pharmaceutical sciences.

[11]  Kenneth S. Suslick,et al.  Ultrasound: Its Chemical, Physical, and Biological Effects , 1988 .

[12]  J. Kost,et al.  Ultrasound-enhanced polymer degradation and release of incorporated substances. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Scheuplein,et al.  Permeability of the Skin , 1971 .

[14]  K. Tachibana Transdermal Delivery of Insulin to Alloxan-Diabetic Rabbits by Ultrasound Exposure , 1992, Pharmaceutical Research.

[15]  External control of drug release: controlled release of insulin from a hydrophilic polymer implant by ultrasound irradiation in diabetic rats , 1988, The Journal of pharmacy and pharmacology.